| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
|
J Invest Dermatol
|
2009
|
2.94
|
|
2
|
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
|
Exp Hematol
|
2004
|
2.81
|
|
3
|
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
|
Haematologica
|
2005
|
2.66
|
|
4
|
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
|
Blood
|
2004
|
2.41
|
|
5
|
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.
|
Blood
|
2007
|
2.36
|
|
6
|
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
|
J Clin Oncol
|
2007
|
2.26
|
|
7
|
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
|
Haematologica
|
2007
|
2.03
|
|
8
|
Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.
|
J Clin Oncol
|
2011
|
1.80
|
|
9
|
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.
|
Blood
|
2011
|
1.71
|
|
10
|
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
|
Blood
|
2010
|
1.55
|
|
11
|
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
|
Blood
|
2002
|
1.54
|
|
12
|
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
|
Blood
|
2003
|
1.49
|
|
13
|
Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
|
Haematologica
|
2007
|
1.42
|
|
14
|
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia.
|
Pediatrics
|
2005
|
1.39
|
|
15
|
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study.
|
Blood
|
2002
|
1.37
|
|
16
|
Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.
|
J Immunol
|
2008
|
1.29
|
|
17
|
Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
|
Blood
|
2005
|
1.28
|
|
18
|
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
|
J Clin Oncol
|
2008
|
1.25
|
|
19
|
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
|
Br J Haematol
|
2010
|
1.16
|
|
20
|
Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
|
Eur J Hum Genet
|
2008
|
1.14
|
|
21
|
Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey.
|
J Pediatr
|
2004
|
1.09
|
|
22
|
Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
|
J Clin Oncol
|
2003
|
1.09
|
|
23
|
Childhood acute leukemia, early common infections, and allergy: The ESCALE Study.
|
Am J Epidemiol
|
2010
|
1.04
|
|
24
|
Road traffic and childhood leukemia: the ESCALE study (SFCE).
|
Environ Health Perspect
|
2010
|
1.03
|
|
25
|
[Standards, options and recommendations for nutritional support in bone marrow transplant patients].
|
Bull Cancer
|
2002
|
1.01
|
|
26
|
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
|
Orphanet J Rare Dis
|
2012
|
1.01
|
|
27
|
Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.
|
Br J Haematol
|
2005
|
0.99
|
|
28
|
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
|
J Allergy Clin Immunol
|
2011
|
0.97
|
|
29
|
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
|
Pediatr Blood Cancer
|
2009
|
0.95
|
|
30
|
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.
|
Exp Hematol
|
2012
|
0.94
|
|
31
|
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
|
Exp Hematol
|
2008
|
0.94
|
|
32
|
Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
|
Transfusion
|
2007
|
0.90
|
|
33
|
Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002.
|
Blood
|
2003
|
0.89
|
|
34
|
Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
|
Biomed Mater Eng
|
2009
|
0.89
|
|
35
|
Significance of molecular quantification of minimal residual disease in metastatic neuroblastoma.
|
J Hematother Stem Cell Res
|
2003
|
0.89
|
|
36
|
Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.
|
Blood
|
2011
|
0.88
|
|
37
|
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
|
Exp Hematol
|
2013
|
0.88
|
|
38
|
Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE).
|
Cancer Causes Control
|
2011
|
0.87
|
|
39
|
Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells.
|
Transfusion
|
2003
|
0.87
|
|
40
|
Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail.
|
Biochim Biophys Acta
|
2002
|
0.86
|
|
41
|
Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy.
|
J Immunother
|
2010
|
0.86
|
|
42
|
Frequency of thrombocytopenia and large platelets correlates neither with conotruncal cardiac anomalies nor immunological features in the chromosome 22q11.2 deletion syndrome.
|
Eur J Pediatr
|
2004
|
0.85
|
|
43
|
The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.
|
Transpl Immunol
|
2011
|
0.85
|
|
44
|
Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.
|
Hum Genet
|
2004
|
0.85
|
|
45
|
Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly.
|
Blood
|
2010
|
0.84
|
|
46
|
T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome.
|
Br J Haematol
|
2002
|
0.83
|
|
47
|
The WHIM syndrome shows a peculiar dysgranulopoiesis: myelokathexis.
|
Br J Haematol
|
2006
|
0.83
|
|
48
|
Comparative evaluation of schistocyte counting by an automated method and by microscopic determination.
|
Am J Clin Pathol
|
2004
|
0.83
|
|
49
|
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.
|
Br J Haematol
|
2014
|
0.82
|
|
50
|
Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up.
|
Clin Immunol
|
2008
|
0.82
|
|
51
|
Weight-based strategy of dose administration in children using intravenous busulfan: clinical and pharmacokinetic results.
|
Pediatr Blood Cancer
|
2011
|
0.82
|
|
52
|
First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
|
Eur J Cancer
|
2008
|
0.81
|
|
53
|
Chromosomally integrated HHV-6: slow decrease of HHV-6 viral load after hematopoietic stem-cell transplantation.
|
Transplantation
|
2009
|
0.80
|
|
54
|
A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
|
Hum Genet
|
2002
|
0.80
|
|
55
|
Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.
|
J Clin Microbiol
|
2010
|
0.80
|
|
56
|
French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
|
Biol Blood Marrow Transplant
|
2012
|
0.79
|
|
57
|
Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?
|
Blood
|
2011
|
0.79
|
|
58
|
Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms.
|
Cancer Causes Control
|
2013
|
0.78
|
|
59
|
Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).
|
Int J Epidemiol
|
2007
|
0.78
|
|
60
|
Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency.
|
J Clin Immunol
|
2011
|
0.77
|
|
61
|
Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
|
Transplantation
|
2013
|
0.77
|
|
62
|
Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment.
|
J Leukoc Biol
|
2007
|
0.77
|
|
63
|
Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation.
|
J Clin Virol
|
2009
|
0.77
|
|
64
|
Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.
|
Br J Haematol
|
2014
|
0.76
|
|
65
|
Extracorporeal photochemotherapy for graft versus host disease in pediatric patients.
|
Transfus Apher Sci
|
2003
|
0.76
|
|
66
|
Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
|
J Clin Immunol
|
2012
|
0.76
|
|
67
|
Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients.
|
J Hematother Stem Cell Res
|
2002
|
0.75
|
|
68
|
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2003
|
0.75
|
|
69
|
The c.273+11dup genetic change in the WAS gene is a functionally neutral polymorphism.
|
Eur J Haematol
|
2011
|
0.75
|
|
70
|
Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
|
Eur J Pediatr
|
2002
|
0.75
|